Growth Metrics

Arcus Biosciences (RCUS) Change in Acquisitions & Divestments (2017 - 2022)

Arcus Biosciences has reported Change in Acquisitions & Divestments over the past 6 years, most recently at $228.0 million for Q3 2022.

  • Quarterly results put Change in Acquisitions & Divestments at $228.0 million for Q3 2022, up 70.93% from a year ago — trailing twelve months through Sep 2022 was $608.8 million (down 18.19% YoY), and the annual figure for FY2021 was $690.1 million, up 124.53%.
  • Change in Acquisitions & Divestments for Q3 2022 was $228.0 million at Arcus Biosciences, up from $169.0 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for RCUS hit a ceiling of $251.4 million in Q1 2021 and a floor of $25.6 million in Q1 2018.
  • Median Change in Acquisitions & Divestments over the past 5 years was $87.3 million (2019), compared with a mean of $102.6 million.
  • Biggest five-year swings in Change in Acquisitions & Divestments: surged 411.42% in 2021 and later crashed 62.68% in 2022.
  • Arcus Biosciences' Change in Acquisitions & Divestments stood at $42.3 million in 2018, then surged by 31.59% to $55.6 million in 2019, then soared by 209.42% to $172.0 million in 2020, then plummeted by 31.45% to $117.9 million in 2021, then soared by 93.36% to $228.0 million in 2022.
  • The last three reported values for Change in Acquisitions & Divestments were $228.0 million (Q3 2022), $169.0 million (Q2 2022), and $93.8 million (Q1 2022) per Business Quant data.